Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts. - Wikidata - wikimedia - TriplyDB

Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.

Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.

http://www.wikidata.org/entity/Q37222032

about

Disruption of Transplant Tolerance by an "Incognito" Form of CD8 T Cell-Dependent Memory.Maternal Immunity and the Natural History of Congenital Human Cytomegalovirus Infection

P2860

Q40380028-C22444E4-2E12-4E13-9723-CAF947FD8A74 Q58801058-E227FD10-1FDD-4FA8-96E5-31747B8418EA

P2860

Rat Cytomegalovirus Vaccine Prevents Accelerated Chronic Rejection in CMV-Naïve Recipients of Infected Donor Allograft Hearts.

http://www.wikidata.org/entity/Q37222032

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 12 March 2015

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@en

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@nl

type

label

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@en

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@nl

prefLabel

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@en

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@nl

P1433

Q37222032-B69F5560-93CD-4797-B1C2-D387FAF2FCF2

P1476

Q37222032-4ED467CF-8DC7-4B59-B8DC-DDC6AAFFCBFE

P2093

Q37222032-0B0134AA-250B-40A8-9C6E-9282167E870D

Q37222032-0F245A46-9E73-42D5-9545-98AB8597BAD9

Q37222032-433F5EBA-57EF-44C0-9BBE-C9027778D028

Q37222032-4D46942B-AA49-43FE-8C33-02467AF6F98F

Q37222032-5A0830E3-4AF1-4AFC-8022-7FB069322B84

Q37222032-63209A4D-4D60-42BF-992F-8CF81FD556EA

Q37222032-7323FD57-E214-4522-8425-B1D62480942C

Q37222032-7EAA714F-8109-4E2B-A9A5-93B548EFC761

Q37222032-92578728-3303-4D58-B27D-0B7716B15468

Q37222032-9475DFC9-27B6-41B5-9941-D070EC718EFC

P2860

Q37222032-034384CE-58E6-4AEB-8900-839A490F105C

Q37222032-11D786BB-BCF0-48B8-83B8-299A5F429FF8

Q37222032-2194B9C2-6121-4544-9EC5-4704DE970FFB

Q37222032-2F23D644-FAAC-4169-B93C-F119D835A43E

Q37222032-344CDD97-9343-4B48-B88A-95BFA549FC6A

Q37222032-385D5DE4-6882-42F9-A58F-2B283B3861B5

Q37222032-3D033D03-033A-4AE1-878D-8B6946CE66AC

Q37222032-3F3CEB3A-EF48-47A0-8290-57D915DAD056

Q37222032-4B87218A-23EA-4297-A1E9-193C8942ECDC

Q37222032-4D9C839E-A5C9-4039-BFF1-91EC219E3EDC

P304

Q37222032-036CC1AD-8A43-4497-B3F8-6761D9F84206

P31

Q37222032-72E9C036-2A88-4C13-AB70-586EC739964B

P356

Q37222032-0ED8BE6B-DD45-41A3-861C-8FE36206EAFB

P407

Q37222032-1FFB1C84-0A9A-4D59-B14A-DF38587EA18A

P433

Q37222032-9682EB3A-FBB6-4FA5-8D8D-92F54C480BF8

P478

Q37222032-588BDA8C-1406-47E8-83DA-96AD4BA68AC4

P577

Q37222032-8F11D40F-7E28-4D31-96C4-A9DFF7DEE789

P698

Q37222032-BC519FDE-BE25-48F8-8BBF-536D52E3C64B

P921

Q37222032-53C06230-261F-4ADB-BEFC-FC05607C592C

P932

Q37222032-FB3C9D34-07E8-4098-9713-3007D66D1E31

P356

P1433

American Journal of Transplantation

P1476

Rat Cytomegalovirus Vaccine Pr ...... fected Donor Allograft Hearts.

@en

P2093

A D Streblow

http://www.w3.org/2001/XMLSchema#string

A Perry

http://www.w3.org/2001/XMLSchema#string

C N Kreklywich

http://www.w3.org/2001/XMLSchema#string

C Pallett

http://www.w3.org/2001/XMLSchema#string

D N Streblow

http://www.w3.org/2001/XMLSchema#string

E Hart

http://www.w3.org/2001/XMLSchema#string

I Messaoudi

http://www.w3.org/2001/XMLSchema#string

K Rogers

http://www.w3.org/2001/XMLSchema#string

M Chuop

http://www.w3.org/2001/XMLSchema#string

M Denton

http://www.w3.org/2001/XMLSchema#string

P2860

The antiinflammatory activity of IgG: the intravenous IgG paradox

Vaccinations for Adult Solid-Organ Transplant Recipients: Current Recommendations and Protocols

Elimination of donor-specific alloreactivity prevents cytomegalovirus-accelerated chronic rejection in rat small bowel and heart transplants.

Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant

Evasion of CD8+ T cells is critical for superinfection by cytomegalovirus

Cytomegalovirus infection enhances smooth muscle cell proliferation and intimal thickening of rat aortic allografts.

Cytomegalovirus microRNA expression is tissue specific and is associated with persistence

Cytomegalovirus-mediated upregulation of chemokine expression correlates with the acceleration of chronic rejection in rat heart transplants.

Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial

Glycoprotein B vaccine is capable of boosting both antibody and CD4 T-cell responses to cytomegalovirus in chronically infected women.

P304

1805-1816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/AJT.13188

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25766876

http://www.w3.org/2001/XMLSchema#string

P921

Cytomegalovirus

P932

5006870

http://www.w3.org/2001/XMLSchema#string